Cargando…
S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
BACKGROUND: Cognitive dysfunctions have long been observed in patients with schizophrenia, while cognitive symptoms are receiving a lot of attention due to the fact they can be considered core symptoms of schizophrenia. Cerebral blood flow has been by some researchers associated with cognitive funct...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234574/ http://dx.doi.org/10.1093/schbul/sbaa031.281 |
_version_ | 1783535795302301696 |
---|---|
author | Peitl, Vjekoslav Silić, Ante Ostojić, Draženka Aukst Margetić, Branka Markoš, Ines Šiško Bogović Dijaković, Anamarija Rendulić, Ana Karlović, Dalibor |
author_facet | Peitl, Vjekoslav Silić, Ante Ostojić, Draženka Aukst Margetić, Branka Markoš, Ines Šiško Bogović Dijaković, Anamarija Rendulić, Ana Karlović, Dalibor |
author_sort | Peitl, Vjekoslav |
collection | PubMed |
description | BACKGROUND: Cognitive dysfunctions have long been observed in patients with schizophrenia, while cognitive symptoms are receiving a lot of attention due to the fact they can be considered core symptoms of schizophrenia. Cerebral blood flow has been by some researchers associated with cognitive functioning, or at least some aspects of cognitive functions. Because of its distinctive psychopharmacologic properties, aripiprazole is deemed a substantially different antipsychotic compared to the majority of the available compounds. It has been hypothesised that due to this fact it could have beneficial effects especially on cognition in schizophrenia. In line with that thought, the objective of this study was to investigate whether use of an atypical antipsychotic aripiprazole has beneficial effects on cerebral blood flow and cognitive functioning in patients with a first episode of schizophrenia during a three month treatment. METHODS: Forty patients were included in the ongoing study. At baseline and at three month follow up schizophrenia symptomatology was assessed by PANSS, cognitive functions by 5-KOG screening instrument for cognition in psychiatry, while cerebral blood flow was assessed by 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO) using a SPECT technique. RESULTS: After three months of treatment, we observed a significant improvement of schizophrenia symptoms and cognitive functions, measured by PANSS and 5-KOG, with all of the five subscales of the latter and its total score being significantly higher than at baseline (p<0.05). Similarly, cerebral blood-flow measured by SPECT improved at three months follow up compared to baseline. DISCUSSION: Use of aripiprazole in first episode patients with schizophrenia is associated with increased fronto-temporal cerebral blood flow and improvement of schizophrenia symptomatology, including cognition indices. Although we cannot confirm it directly, it is possible that improved fronto-temporal cerebral blood flow led to the improvement in cognition indices. |
format | Online Article Text |
id | pubmed-7234574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72345742020-05-23 S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS Peitl, Vjekoslav Silić, Ante Ostojić, Draženka Aukst Margetić, Branka Markoš, Ines Šiško Bogović Dijaković, Anamarija Rendulić, Ana Karlović, Dalibor Schizophr Bull Poster Session I BACKGROUND: Cognitive dysfunctions have long been observed in patients with schizophrenia, while cognitive symptoms are receiving a lot of attention due to the fact they can be considered core symptoms of schizophrenia. Cerebral blood flow has been by some researchers associated with cognitive functioning, or at least some aspects of cognitive functions. Because of its distinctive psychopharmacologic properties, aripiprazole is deemed a substantially different antipsychotic compared to the majority of the available compounds. It has been hypothesised that due to this fact it could have beneficial effects especially on cognition in schizophrenia. In line with that thought, the objective of this study was to investigate whether use of an atypical antipsychotic aripiprazole has beneficial effects on cerebral blood flow and cognitive functioning in patients with a first episode of schizophrenia during a three month treatment. METHODS: Forty patients were included in the ongoing study. At baseline and at three month follow up schizophrenia symptomatology was assessed by PANSS, cognitive functions by 5-KOG screening instrument for cognition in psychiatry, while cerebral blood flow was assessed by 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO) using a SPECT technique. RESULTS: After three months of treatment, we observed a significant improvement of schizophrenia symptoms and cognitive functions, measured by PANSS and 5-KOG, with all of the five subscales of the latter and its total score being significantly higher than at baseline (p<0.05). Similarly, cerebral blood-flow measured by SPECT improved at three months follow up compared to baseline. DISCUSSION: Use of aripiprazole in first episode patients with schizophrenia is associated with increased fronto-temporal cerebral blood flow and improvement of schizophrenia symptomatology, including cognition indices. Although we cannot confirm it directly, it is possible that improved fronto-temporal cerebral blood flow led to the improvement in cognition indices. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234574/ http://dx.doi.org/10.1093/schbul/sbaa031.281 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Session I Peitl, Vjekoslav Silić, Ante Ostojić, Draženka Aukst Margetić, Branka Markoš, Ines Šiško Bogović Dijaković, Anamarija Rendulić, Ana Karlović, Dalibor S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS |
title | S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS |
title_full | S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS |
title_fullStr | S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS |
title_full_unstemmed | S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS |
title_short | S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS |
title_sort | s215. fronto-temporal cerebral blood flow and cognitive functioning in patients with first episode psychoses treated with aripiprazole: preliminary findings |
topic | Poster Session I |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234574/ http://dx.doi.org/10.1093/schbul/sbaa031.281 |
work_keys_str_mv | AT peitlvjekoslav s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT silicante s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT ostojicdrazenka s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT aukstmargeticbranka s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT markosinessisko s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT bogovicdijakovicanamarija s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT rendulicana s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings AT karlovicdalibor s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings |